|
Reporting
adverse reactions
At
a seminar on pharmaceutical drug discovery organised in Mumbai
recently, a high profile foreign speaker mentioned that rapid
advances in genetics and genomics would soon bring us to a
stage where therapy would be individualized and that there
would be no need for a doctor’s intervention because
diagnosis too by then will be automated, accurate and specific.
Use
of cadaveric blood transfusion in disasters
Blood
is one component in healthcare that is always in shortage.
So one can imagine what the situation will be like at the
time of mass disasters.
Insulin
mfrs slash vial prices but retain margins on cartridges
Novo
Nordisk and Eli Lilly, the two best-sellers of insulin in
India, have effected a deep cut in prices of human insulin
by 25 per cent and 30 per cent respectively.
GCP
Queries
Understanding
the overall issues in GCP and adopting procedural norms as
per national and international guidelines becomes imperative
in present times, especially for India which is turning out
to be the hub of clinical research activities. To enlighten
readers on such issues, Dr Arun D Bhatt, well known clinical
pharmacologist from Mumbai will answer queries raised on this
subject.
|
